Chris T. Bitterman - Mar 23, 2024 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Vice Pres Sales & Marketing
Signature
Chris T. Bitterman by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Mar 23, 2024
Transactions value $
$3,629
Form type
4
Date filed
3/26/2024, 08:25 PM
Previous filing
Mar 27, 2023
Next filing
Mar 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Tax liability -$1.07K -593 -11.24% $1.81 4.68K Mar 23, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPIX Options (right to buy) Award $4.7K +2.75K +26.19% $1.71 13.3K Mar 25, 2024 Common Stock 2.75K $1.71 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.